{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:32:22Z","timestamp":1784629942746,"version":"3.55.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.ymgme.2011.08.009","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T22:17:05Z","timestamp":1313533025000},"page":"S19-S25","source":"Crossref","is-referenced-by-count":64,"special_numbering":"S","title":["Up to date knowledge on different treatment strategies for phenylketonuria"],"prefix":"10.1016","volume":"104","author":[{"given":"Amaya","family":"B\u00e9langer-Quintana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary O.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania C.","family":"Muntau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2011.08.009_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","article-title":"Hyperphenylalaninemia: phenylalanine hydroxylase deficiency","author":"Scriver","year":"2001"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0010","first-page":"ix","article-title":"Excretion of conjugated phenylacetic acid in phenylketonuria","volume":"49","author":"Woolf","year":"1951","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(53)90473-5","article-title":"Influence of phenylalanine intake on phenylketonuria","volume":"265","author":"Bickel","year":"1953","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0020","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.108.4.972","article-title":"National institutes of health consensus development conference statement: phenylketonuria: screening and management","volume":"108","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2010.05.017","article-title":"Suboptimal outcome in patients with PKU treated early with diet alone: revisiting the evidence","volume":"101","author":"Enns","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0030","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1542\/peds.112.S4.1548","article-title":"Pregnancy experiences in the woman with mild hyperphenylalaninemia","volume":"112","author":"Levy","year":"2003","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ymgme.2011.08.009_bb0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1542\/peds.2009-3584","article-title":"Challenges and pitfalls in the management of phenylketonuria","volume":"126","author":"Feillet","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0040","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0002-8223(03)00983-0","article-title":"Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy","volume":"103","author":"Acosta","year":"2003","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1067\/mpd.2002.126455","article-title":"Protein insufficiency and linear growth restriction in phenylketonuria","volume":"141","author":"Arnold","year":"2002","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1024063726046","article-title":"Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria","volume":"26","author":"Dobbelaere","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00431-002-1091-9","article-title":"The impact of the control of serum phenylalanine levels on osteopenia in patients with phenylketonuria","volume":"161","author":"Barat","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0060","first-page":"6","article-title":"Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU)","volume":"26","author":"Simon","year":"2008","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ejcn.2010.258","article-title":"Blood phenylalanine control in phenylketonuria: a survey of 10 European centres","volume":"65","author":"Ahring","year":"2011","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0070","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10545-010-9073-y","article-title":"The reality of dietary compliance in the management of phenylketonuria","volume":"33","author":"MacDonald","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","article-title":"Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis","volume":"92","author":"Waisbren","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1017\/S0012162205000861","article-title":"Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population","volume":"47","author":"Gassi\u00f3","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0085","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.ymgme.2009.10.183","article-title":"Psychosocial aspects of PKU: hidden disabilities\u2014a review","volume":"99","author":"Gentile","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0090","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.ymgme.2009.10.007","article-title":"Executive function in early-treated phenylketonuria: profile and underlying mechanisms","volume":"99","author":"Christ","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1399-0004.2008.01101.x","article-title":"Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria","volume":"75","author":"Sharman","year":"2009","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/B:BOLI.0000028781.94251.1f","article-title":"Executive function impairment in early-treated PKU subjects with normal mental development","volume":"27","author":"Leuzzi","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0105","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.ymgme.2009.10.182","article-title":"Psychiatric symptoms and disorders in phenylketonuria","volume":"99","author":"Brumm","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10545-007-0556-4","article-title":"Double blind placebo control trial of large neutral aminoacids in treatment of PKU: effect on blood phenylalanine","volume":"30","author":"Matalon","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10545-008-0952-4","article-title":"Nutritional management of PKU with glycomacropeptide from cheese whey","volume":"32","author":"Ney","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0120","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10545-010-9099-1","article-title":"Therapeutic liver repopulation for phenylketonuria","volume":"33","author":"Harding","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0125","series-title":"PKU and BH4. Advances in Phenylketonuria and Tetrahydrobiopterin","article-title":"Tetrahydrobiopterin deficiencies with hyperphenylalaninemia","author":"Hyghland","year":"2006"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF00441135","article-title":"Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man","volume":"138","author":"Niederwieser","year":"1982","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0135","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3476(99)70138-1","article-title":"Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"135","author":"Kure","year":"1999","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0140","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1096-7192(02)00171-3","article-title":"High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1,919 patients observed from 1988 to 2002","volume":"77","author":"Bernegger","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0145","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa021654","article-title":"Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria","volume":"347","author":"Muntau","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0150","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/humu.9117","article-title":"Tetrahydrobiopterin sensitivity in German patients with mild phenylalanine hydroxylase deficiency","volume":"21","author":"Lindner","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymgme.2004.06.007","article-title":"Tetrahydrobiopterin responsiveness: results of the BH4 loading test in 31 Spanish PKU patients and correlation with their genotype","volume":"83","author":"Desviat","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0160","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.ymgme.2005.06.024","article-title":"Response of patients with phenylketonuria in the US to tetrahydrobiopterin","volume":"86","author":"Matalon","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0165","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.ymgme.2005.06.008","article-title":"Tetrahydrobiopterin-responsive phenylketonuria: the New South Wales experience","volume":"86","author":"Mitchell","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/humu.20637","article-title":"Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"29","author":"Zurfl\u00fch","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/jhg.2009.37","article-title":"A limited spectrum of phenylalanine hydroxylase mutations is observed in phenylketonuria patients in western Poland and implications for treatment with 6R tetrahydrobiopterin","volume":"54","author":"Dobrowolski","year":"2009","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ymgme.2009.03.009","article-title":"Genotype-predicted tetrahydrobiopterin (BH4)-responsiveness and molecular genetics in Croatian patients with phenylalanine hydroxylase (PAH) deficiency","volume":"97","author":"Karaci\u0107","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0185","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ymgme.2009.01.002","article-title":"Optimizing the use of sapropterin (BH(4)) in the management of phenylketonuria","volume":"96","author":"Blau","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0190","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2007.09.017","article-title":"Recommendations for evaluation of responsiveness to tetrahydrobiopterin (BH(4)) in phenylketonuria and its use in treatment","volume":"92","author":"Levy","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0195","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.ymgme.2005.09.014","article-title":"Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study","volume":"86","author":"Fiege","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0200","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ymgme.2007.07.013","article-title":"Effects of tetrahydrobiopterin and phenylalanine on in vivo human phenylalanine hydroxylase by phenylalanine breath test","volume":"92","author":"Okano","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0205","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1086\/521879","article-title":"Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases","volume":"81","author":"Pey","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2008.05.013","article-title":"Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability","volume":"83","author":"Gersting","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0215","doi-asserted-by":"crossref","first-page":"16903","DOI":"10.1073\/pnas.0407256101","article-title":"Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations","volume":"101","author":"Erlandsen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0220","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/humu.20097","article-title":"Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations","volume":"24","author":"Pey","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0225","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ymgme.2005.06.009","article-title":"Kinetic and stability analysis of PKU mutations identified in BH4-responsive patients","volume":"86","author":"P\u00e9rez","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0230","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/hmg\/ddq085","article-title":"Pahenu1 is a mouse model for tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivo","volume":"19","author":"Gersting","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0235","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ymgme.2005.05.013","article-title":"Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria","volume":"86","author":"Hennermann","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0240","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10545-008-0940-8","article-title":"Significance of genotype in tetrahydrobiopterin-responsive phenylketonuria","volume":"32","author":"Trefz","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0245","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddr165","article-title":"The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response","author":"Staudigl","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0250","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.earlhumdev.2008.01.003","article-title":"Evaluation of neonatal BH4 loading test in neonates screened for hyperphenylalaninemia","volume":"84","author":"Feillet","year":"2008","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0255","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ymgme.2008.03.016","article-title":"Development of a model for assessment of phenylalanine hydroxylase activity in newborns with phenylketonuria receiving tetrahydrobiopterin: a potential for practical implementation","volume":"94","author":"Bik-Multanowski","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0260","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jpeds.2010.08.016","article-title":"Tetrahydrobiopterin therapy for phenylketonuria in infants and young children","volume":"158","author":"Burton","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0265","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1002\/ajmg.a.32562","article-title":"Safety and efficacy of 22weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria","volume":"15","author":"Lee","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0270","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2165\/0003088-200847120-00006","article-title":"Pharmacokinetics of sapropterin in patients with phenylketonuria","volume":"47","author":"Feillet","year":"2008","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0275","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ymgme.2003.11.008","article-title":"Long-term follow-up of a patient with mild tetrahydrobiopterin-responsive phenylketonuria","volume":"81","author":"Cerone","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0280","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.ymgme.2005.05.014","article-title":"Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy","volume":"86","author":"Lambruschini","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0285","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.ymgme.2005.07.024","article-title":"Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin","volume":"86","author":"B\u00e9langer-Quintana","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0290","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.ymgme.2005.06.026","article-title":"Long-term treatment of patients with mild and classical phenylketonuria by tetrahydrobiopterin","volume":"86","author":"Trefz","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0295","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s10545-007-0567-1","article-title":"The tetrahydrobiopterin loading test in 36 patients with hyperphenylalaninaemia: evaluation of response and subsequent treatment","volume":"30","author":"B\u00f3veda","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0300","article-title":"Long-term follow-up of patients with phenylketonuria receiving tetrahydrobiopterin treatment","volume":"9","author":"Trefz","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0305","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.bcp.2010.07.042","article-title":"New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1\/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"80","author":"Lagler","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0310","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.clinthera.2010.02.012","article-title":"Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults","volume":"32","author":"Musson","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0315","first-page":"1","article-title":"Adjusting diet with sapropterin in phenylketonuria: what factors should be considered?","volume":"5","author":"Macdonald","year":"2011","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0320","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.TIN.0000318911.54358.a1","article-title":"Recommendations for personalized diet adjustments based on patients response to tetrahydrobiopterin (BH4) in phenylketonuria","volume":"23","author":"Singh","year":"2008","journal-title":"Top. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0325","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1203\/01.PDR.0000111283.91564.7E","article-title":"Long-term treatment and diagnosis of tetrahydrobiopterin-responsive hyperphenylalaninemia with a mutant phenylalanine hydroxylase gene","volume":"55","author":"Shintaku","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0330","first-page":"77","article-title":"Diagnosis of tetrahydrobiopterin (BH4) responsive mild phenylketonuria in Japan over the past 10years","volume":"37","author":"Shintaku","year":"2008","journal-title":"Ann. Acad. Med. Singapore"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0335","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ymgme.2010.06.015","article-title":"Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU)","volume":"101","author":"Burton","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0340","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10545-010-9224-1","article-title":"BH(4) therapy impacts the nutrition status and intake in children with phenylketonuria: 2-year follow-up","volume":"33","author":"Singh","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0345","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.clinbiochem.2009.11.013","article-title":"Long-chain polyunsaturated fatty acid status in phenylketonuric patients treated with tetrahydrobiopterin","volume":"43","author":"Vilaseca","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0350","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.ymgme.2009.10.187","article-title":"Cognitive functions in patients with phenylketonuria in long-term treatment with tetrahydrobiopterin","volume":"99","author":"Gassi\u00f3","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0355","first-page":"CD008005","article-title":"Sapropterin dihydrochloride for phenylketonuria","volume":"16","author":"Somaraju","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0360","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00431-005-1638-7","article-title":"Severe mucitis after sublingual administration of tetrahydrobiopterin in a patient with tetrahydrobiopterin-responsive phenylketonuria","volume":"164","author":"Opladen","year":"2005","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0365","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s10545-007-0605-z","article-title":"The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study","volume":"30","author":"Burton","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0370","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(07)61234-3","article-title":"Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study","volume":"370","author":"Levy","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0375","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpeds.2008.11.040","article-title":"Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study","volume":"154","author":"Trefz","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0380","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1542\/peds.2008-2783","article-title":"Maternal phenylketonuria and tetrahydrobiopterin","volume":"122","author":"Koch","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0385","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1358\/dot.2010.46.8.1509557","article-title":"Sapropterin dihydrochloride: a new drug and a new concept in the management of phenylketonuria","volume":"46","author":"Trefz","year":"2010","journal-title":"Drugs Today"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0390","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ymthe.2004.05.001","article-title":"Trends in enzyme therapy for phenylketonuria","volume":"10","author":"Kim","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0395","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/bms.1200110609","article-title":"The metabolism of cinnamic acid by healthy and phenylketonuric adults: a kinetic study","volume":"11","author":"Hoskins","year":"1984","journal-title":"Biomed. Mass Spectrom."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0400","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(80)90944-7","article-title":"Enzymatic control of phenylalanine intake in phenylketonuria","volume":"1","author":"Hoskins","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0405","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/10731199509117980","article-title":"Enzyme replacement therapy in ENU2 phenylketonuric mice using oral microencapsulated phenylalanine ammonia-lyase: a preliminary report","volume":"23","author":"Safos","year":"1995","journal-title":"Artif. Cells Blood Substit. Immobil. Biotechnol."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0410","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1126\/science.567372","article-title":"Phenylalanine depletion for the management of phenylketonuria: use of enzyme reactors with immobilized enzymes","volume":"201","author":"Ambrus","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0415","doi-asserted-by":"crossref","first-page":"20894","DOI":"10.1073\/pnas.0808421105","article-title":"Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria","volume":"105","author":"Sarkissian","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0420","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1073\/pnas.96.5.2339","article-title":"A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase","volume":"96","author":"Sarkissian","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0425","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2007.04.015","article-title":"Structure-based epitope and PEGylation sites mapping of phenylalanine ammonia-lyase for enzyme substitution treatment of phenylketonuria","volume":"91","author":"Gamez","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0430","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2009.09.002","article-title":"Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria","volume":"99","author":"Kang","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0435","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/306151a0","article-title":"Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria","volume":"306","author":"Woo","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0440","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.3856322","article-title":"Gene transfer and expression of human phenylalanine hydroxylase","volume":"228","author":"Ledley","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2011.08.009_bb0445","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.gt.3302678","article-title":"Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2\/8 vector-mediated gene therapy in murine phenylketonuria","volume":"13","author":"Harding","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0450","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.gt.3302684","article-title":"Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer","volume":"13","author":"Ding","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0455","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/mt.2008.17","article-title":"Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating system","volume":"16","author":"Ding","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0460","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2009.127","article-title":"Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria","volume":"21","author":"Rebuffat","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2011.08.009_bb0465","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/gt.2008.64","article-title":"Potential of AAV vectors in the treatment of metabolic disease","volume":"15","author":"Alexander","year":"2008","journal-title":"Gene Ther."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719211002629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719211002629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T20:48:55Z","timestamp":1686257335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719211002629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":93,"alternative-id":["S1096719211002629"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2011.08.009","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}